Maximum quantity allowed is 999
请选择数量
CAS RN: 133052-90-1 | 產品號碼: B5781
Bisindolylmaleimide I
×
![]()
×
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
產品規格
| Appearance | Light yellow to Yellow to Orange powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Melting point | 268.0 to 272.0 °C |
| NMR | confirm to structure |
性質
| 熔點 | 270 °C |
| Maximum Wavelength | 466(EtOH) nm |
GHS
相關法規
| RTECS # | UX9590000 |
運輸資料
| HS編碼* | 2933.99-000 |
Application
Bisindolylmaleimide I: A Potent, Selective and Competitive Inhibitor of Protein Kinase C (PKC)
Protein kinase C (PKC) isoforms, a family of serine/threonine protein kinases, are thought to mediate numerous signal transduction processes including the control of cell growth, differentiation and homeostasis. Bisindolylmaleimide I (GF 109203X) a potent, selective and competitive inhibitor of PKC isoforms.1-3) Bisindolylmaleimide I (GF 109203X) also inhibits LRRK2 (Leucine-rich repeat kinase 2) –G2019S that is a promising therapeutic target for the treatment of Parkinson's disease.4) (The product is for research purpose only.)
References
- 1) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
- 2) The protein kinase C inhibitors Ro318220 and GF109203X are equally potent inhibitors of MAPKAP kinase-1β (Rsk-2) and p70S6 kinase
- 3) The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31-8220) are potent inhibitors of glycogen synthase kinase-3 activity
- 4) Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
TCIMail
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。